3 Best Biology Doctoral Degree Programs in Japan for 2024

What kind of image do you have when you think of hematology? Many people may have the impression that it is "difficult," "difficult to understand," "difficult," and "cannot do this."Certainly, in hematology, cells are finely discriminated under a microscope, and an antigen that does not mean CD △△ is examined by a surface antigen test called FACS, and many genes such as "code" are examined in chromosomal tests and gene PCR tests. Search for a name. It also uses a large number of anti-cancer drugs, which may also be the cause of "blood dislike".But don't worry. There are only a limited number of points to be noted in testing and treatment in individual cases, and certain basic rules can be used to understand most of the testing and treatment. And if you have little experience with the instructor in the clinical setting, you will not have much trouble in reality. Rather, you will find that hematology is more "internal medicine" than other internal medicine. Blood cells and coagulation factors are "systemic organs."Since blood abnormalities spread to all organs such as the circulatory system, digestive system, respiratory system, and renal urinary system, the range of medical care in hematology is wide, and in that sense, it has the aspect of being the ultimate "comprehensive internal medicine".We sincerely look forward to the participation of teachers who aim to become generalists.

Tokyo Women’s Medical University School of Medicine underwent a multifaceted medical education assessment by the Japan Accreditation Council for Medical Education (JACME) in November 2019 and was accredited as meeting the global standards in June 2020. Various educational approaches implemented by the entire School of Medicine were highly rated, demonstrating that students receive the highest levels of education in Japan. We are all committed to continuously innovating educational programs and further improving the quality of education. In order to nurture medical professionals who can promote research in medical sciences and make further beneficial contributions to medical sciences and society, we have established the Graduate School of Medical Science (usually a 4-year doctoral course and a 3-year course for exceptional cases). The Ph.D. degree is given to students who have earned sufficient credits and passed the thesis review and final examination. We also offer a basic research doctor training program for undergraduates (3 to 6-year students). This program includes both junior residential training and first and second-year graduate courses. By successfully completing this program, the student earns credits in graduate school, earning a Ph.D. in 4 years after their graduation.

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease (ATD). The general prevalence is said to be about 150 / 100,000, but there are reports that the number of elderly people in their 70s is over 800, and the number of PD patients is already increasing in Japan, which is a super-aging society. Lewy body dementias, which is associated with dementia and psychiatric symptoms, is also attracting attention as the number of elderly PDs increases. In addition, since the gene analysis of large family PD in the United States in 1997, the gene analysis of familial PD has been actively performed, but the familial PD family called PARK8 was reported by Kitasato University. .. The pathological condition is a decrease in dopamine in the striatum due to degeneration of the substantia nigra, and drug therapy is the main focus. In recent years, a group of diseases in which a specific host protein becomes sparingly soluble due to its higher-order structural conversion and abnormal proteins accumulate in tissues and cells have attracted attention as conformational diseases. 1998 α-synuclein is the main Lewy body. It is a constituent and is considered to be a typical disease along with ATD. Our group provides state-of-the-art medical treatments with high evidence for related diseases, including Parkinson's disease. Furthermore, in these degenerative diseases, poorly soluble proteins accumulated in tissues and cells cause dysfunction of nerve cells, so suppression or elimination of abnormal proteins is considered to be a therapeutic target, and based on these, part of the pathogenesis and treatment We are promoting research to take on the role.